Resolution of inflammatory colitis with pegfilgrastim treatment in a case of severe congenital neutropenia due to glucose 6 phosphatase catalytic subunit-3 deficiency

Journal of Pediatric Hematology/Oncology

Volumn 36, Issue 5, 2014, Pages

  Kaya, Zühre ^a   Eǧritaş, Ödül ^b   Albayrak, Meryem ^a   Göçün, Pinar Uyar ^c   Koçak, Ülker ^a   Dalgiç, Buket ^b   Gürsel, Türkiz ^a  

^a GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^b Bayindir Hospitals   (Turkey)

^c GAZI UNIVERSITY   (Turkey)

Author keywords

G6PC3 deficiency; inflammatory colitis; pegfilgrastim

Indexed keywords

ALPHA 1 ANTITRYPSIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ABDOMINAL PAIN; AMINO ACID SUBSTITUTION; ARTICLE; ARTIFICIAL VENTILATION; CASE REPORT; CHILD; COLITIS; COLON BIOPSY; COLONOSCOPY; CONSANGUINITY; DIARRHEA; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FEVER; FOLLOW UP; GASTROENTERITIS; GENE; GENE MUTATION; GINGIVA ULCER; GINGIVITIS; GLUCOSE 6 PHOSPHATASE CATALYTIC SUBUNIT 3 DEFICIENCY; GLUCOSE 6 PHOSPHATASE CATALYTIC SUBUNIT 3 GENE; GLYCOGEN STORAGE DISEASE TYPE 1; HOMOZYGOTE; HUMAN; INFANT; INTERSTITIAL PNEUMONIA; LUNG INFECTION; MALNUTRITION; NEUTROPHIL COUNT; PANCOLITIS; PRIORITY JOURNAL; RECURRENT INFECTION; REPEAT PROCEDURE; SCHOOL CHILD; SEVERE CONGENITAL NEUTROPENIA; STOMATITIS; WEIGHT GAIN; WEIGHT REDUCTION;

CHILD; COLITIS; COLITIS, ULCERATIVE; FEMALE; GLUCOSE-6-PHOSPHATASE; GLYCOGEN STORAGE DISEASE TYPE I; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; INFANT; INFLAMMATION; MUTATION; NEUTROPENIA; PROGNOSIS; RECOMBINANT PROTEINS;

EID: 84903757271     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0000000000000079     Document Type: Article

References (22)

1. Boztug? K, Appaswamy G, Ashikov A, et al. A novel syndrome with congenital neutropenia caused by mutations in G6PC3. N Engl J Med. 2009;360:32-43.
2. Jun HS, Lee YM, Cheung YY, et al. Lack of glucose recycling between endoplasmic reticulum and cytoplasm underlies cellular dysfunction in glucose 6 phosphatase b deficient neutrophils in a congenital neutropenia syndrome. Blood. 2010; 116:2783-2792.
3. Visser G, Rake JP, Labrune P, et al. Consensus guidelines for management of glycogen storage disease type 1b-European Study on Glycogen Storage Disease Type 1. Eur J Pediatr. 2002;161:S120-S123.
4. Gatti S, Boztug? K, Pedini A, et al. A case of syndromic neutropenia and mutation in G6PC3. J Pediatr Hematol Oncol. 2011;33:138-140.
5. Banka S, Wynn R, Byers H, et al. G6PC3 mutations cause non-syndromic severe congenital neutropenia. Mol Genet Metab. 2013;108:138-141.
6. Banka S, Newman WG. A clinical and molecular review of ubiquitous glucose-6-phosphatase deficiency caused by G6PC3 mutations. Orphanet J Rare Dis. 2013;8:84.
7. Boztug K, Rosenberg PS, Dorda M, et al. Extended spectrum of human glucose-6 phosphatase catalytic subunit 3 deficiency: novel genotypes and phenotypic variability in severe congenital neutropenia. J Pediatr. 2012;160:679-683.
8. Banka S, Newman WG, Ozgül RK, et al. Mutations in the G6PC3 gene cause Dursun syndrome. Am J Med Genet A. 2010;152A:2609-2611.
9. Banka S, Chervinsky E, Newman WG, et al. Further delineation of the phenotype of severe congenital neutropenia type 4 due to mutations in G6PC3. Eur J Hum Genet. 2011;19:18-22.
10. Fernandez BA, Green JS, Bursey F, et al. Adult siblings with homozygous G6PC3 mutations expand our understanding of the severe congenital neutropenia type 4 (SCN4) phenotype. BMC Med Genet. 2012;13:111.
11. Smith BN, Evans C, Ali A, et al. Phenotypic heterogeneity and evidence of a founder effect associated with G6PC3 mutations in patients with severe congenital neutropenia. Br J Haematol. 2012;158:146-149.
12. Hayee B, Antonopoulos A, Murphy EJ, et al. G6PC3 mutations are associated with a major defect of glycosylation: a novel mechanism for neutrophil dysfunction. Glycobiology. 2011;21:914-924.
13. Begin P, Patey N, Mueller P, et al. Inflammatory bowel disease and T cell lymphopenia in G6PC3 deficiency. J Clin Immunol. 2013;33:520-525.
14. Cullinane AR, Vilboux T, O'Brien K, et al. Homozygosity mapping and whole exome sequencing to detect SLC45A2 and G6PC3 mutations in a single patient with oculocutaneous albinism and neutropenia. J Invest Dermatol. 2011;131:2017-2025.
15. Gitzelmann R, Bosshard NU. Defective neutrophil and monocyte functions in glycogen storage disease type 1b: a literature review. Eur J Pediatr. 1993;152(suppl 1):S33-S38.
16. Cheung YY, Kim SY, Yiu WH, et al. Impaired neutrophil activity and increased susceptibility to bacterial infection in mice lacking glucose-6-phosphatase beta. J Clin Invest. 2007;117:784-793.
17. Roe TF, Coates TD, Thomas DW, et al. Treatment of chronic inflammatory bowel disease in glycogen storage disease type Ib with colony stimulating factors. N Engl J Med. 1992;326: 1666-1669.
18. Alsultan A, Sokol RJ, Lovell MA, et al. Long term G-CSF induced remission of ulcerative colitis like inflammatory bowel disease in a patient with glycogen storage disease Ib and evaluation of associated neutrophil function. Pediatr Blood Cancer. 2010;55:1410-1413.
19. Becker K, Frieling T, Haussinger D. Quantification of fecal alpha 1 antitripsin excretion for assessment of inflammatory bowel diseases. Eur J Med Res. 1998;3:65-70.
20. Henderson P, Anderson NH, Wilson DC. The diagnostic accuracy of fecal calprotectin during the investigation of suspected pediatric inflammatory bowel disease: a systematic review and meta-analysis. Am J Gastroenterol. 2013. doi:10. 1038/ajg.2013.131. [Epub ahead of print].
21. Choi LMR, Guelcher C, Guerrera MF. Novel treatment for severe congenital neutropenia with pegfilgrastim. Blood. 2007;110:4134.
22. Lahteenmaki PM, Jahnukainen K, Pelliniemi TT, et al. Severe congenital neutropenia and pegfilgrastim. Eur J Haematol. 2009;82:75-76.